3 VAN DE GRAAFF DRIVE, BURLINGTON, MA
Fractyl Health, Inc. Files Amendment for 1-for-12 Reverse Stock Split
Approval of Reverse Stock Split Proposal at Fractyl Health Special Meeting
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports Second Quarter 2026 Financial Results and Business Updates
Investor Presentation
Fractyl Health, Inc. 2026 Annual Meeting Results and Director Elections
Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
Reports First Quarter 2026 Financial Results and Business Updates
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
SEC Staff Correspondence
Correspondence